Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 195.50
+19.50 (11.08%)
Oct 16, 2026, 1:59 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 15.55 billion as of October 16, 2026. It is the 14,965th most valuable company in the world and the 536th biggest in Taiwan. Its market cap has increased by 513.12% in one year.
Market Cap
15.55B
Enterprise Value
14.73B
Revenue
n/a
Global Rank
Country Rank
#536 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 15.55B, an increase of 594.22%. That is a compound annual growth rate of 110.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 15.55B | 288.34% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunmax Biotechnology | 21.51B |
| Medigen Vaccine Biologics | 17.33B |
| TaiMed Biologics | 16.69B |
| Ever Supreme Bio Technology | 15.81B |
| Gongwin Biopharm Holdings | 15.32B |
| EirGenix | 15.26B |
| ACRO Biomedical | 14.09B |
| Lumosa Therapeutics | 12.71B |